查看購物車
  • English
  • Japanese
封面
市場調查報告書
商品編碼
1965456

替代蛋白市場－全球產業規模、佔有率、趨勢、機會、預測：按產品類型、應用、地區和競爭格局分類，2021-2031年

Alternative Protein Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, Segmented By Product Type, By Application, By Region & Competition, 2021-2031F
出版日期: | 出版商: TechSci Research | 英文 180 Pages | 商品交期: 2-3個工作天內

價格

We offer 8 hour analyst time for an additional research. Please contact us for the details.

簡介目錄

全球替代蛋白市場預計將從 2025 年的 169.8 億美元成長到 2031 年的 270.4 億美元，複合年成長率為 8.06%。

這些食品被定義為以植物來源原料、發酵製程或動物細胞培養技術生產的食品，旨在複製傳統肉類的感官和營養特性。推動其成長的關鍵因素包括應對氣候變遷的迫切挑戰、全球為確保長期糧食安全而對高效資源利用的需求，以及消費者對多樣化蛋白質來源健康益處的日益關注。受此發展動能影響，根據良好食品研究所（GFI）預測，到2024年，全球植物來源肉類和乳製品替代品的銷售額將達到286億美元。

市場概覽
預測期 2027-2031
市場規模：2025年 169.8億美元
市場規模：2031年 270.4億美元
複合年成長率：2026-2031年 8.06%
成長最快的細分市場 動物飼料
最大的市場 北美洲

然而，該產業面臨許多挑戰，主要源自於嚴峻的投資環境，限制了擴大生產營運所需的資金。資金籌措困難阻礙了企業發展實現技術規模經濟所需的必要基礎設施，導致其在價格上難以與傳統動物產品競爭。根據良好食品研究所（Good Food Institute）預測，到2024年，替代蛋白產業的總資金籌措額僅11億美元。投資資本的萎縮是實現快速產業擴張、確保大眾市場滲透的關鍵障礙。

市場促進因素

擠壓和微發酵技術的突破對於克服阻礙替代蛋白廣泛應用的質地和成本障礙至關重要。具體而言，高水分擠壓技術的創新將能夠生產出類似動物肌肉纖維質地的塊狀肉狀替代產品，而微發酵技術則能夠實現血紅素和酪蛋白等功能性成分的規模化生產。隨著這些技術從實驗室規模的原型走向工業化生產，它們對於實現與傳統肉類的價格競爭力至關重要。根據良好食品研究所發布的《2024年產業趨勢：發酵》報告，預計到2024年至少將有17家發酵設施投入營運或正在規劃建設中，這表明儘管面臨經濟挑戰，全球生物製造能力仍將強勁擴張。這將直接有助於供應鏈的穩定性和成本的降低。

同時，政府的支持政策和法規結構正在為市場合法性和永續研發創造穩定的環境。各國政府日益認知到替代蛋白是提升國家糧食安全和實現氣候目標的重要戰略資產，這促使公共投資和私人獎勵顯著增加，以支持開放取用的研究。根據良好食品研究所發布的《2024年全球政策狀況》報告，到2024年，世界各國政府將在該領域投資約5.1億美元。公共資本的湧入有助於降低早期創新階段的風險，並透過補充私人資金加速商業化進程。這些促進因素的成功也體現在消費者的行為中；據良好食品研究所稱，到2025年，59%的美國家庭將購買植物來源食品，這表明供應增加和製度支持正在有效地推動市場滲透。

市場挑戰

投資限制嚴重阻礙了全球替代蛋白市場的發展，因為其所需的資本不足以擴大生產規模。後期融資管道的匱乏使得製造商無法承擔建造大規模生產設施所需的巨額支出。基礎設施擴張的困難阻礙了企業實現降低單位成本所需的技術規模經濟。因此，替代蛋白產品被迫維持高於傳統肉品的價格，這不僅阻礙了其在消費者中的廣泛普及，也限制了其市場滲透範圍，使其僅限於特定細分市場。

近期數據顯示，植物蛋白產業的資金大幅下降，凸顯了資金籌措資金籌措的嚴重性。根據良好食品研究所（Good Food Institute）預測，到2024年，對植物蛋白公司的投資將降至3.09億美元，年比大幅下降64%。可用資金的急劇減少迫使許多公司暫停或取消了原定的工廠擴建計劃。因此，該行業正艱難地從試點規模的生產過渡到工業化規模的生產，而工業化生產對於實現價格競爭力並與傳統畜牧業有效競爭至關重要。

市場趨勢

將植物來源成分與發酵或培養成分結合的混合產品的興起，正成為解決彈性素食消費者感官限制的一種切實可行的策略。透過組合不同的蛋白質來源，製造商可以提供純植物來源配方難以實現的風味和口感，同時與完全培養的替代品相比，還能最佳化成本結構和營養密度。這種綜合方法正逐漸獲得消費者的認可，成為那些對購買此類產品猶豫不決的消費者更容易接受的選擇。根據Green Queen 2025年7月發表的一篇報導《全球調查：75%的消費者仍然對植物來源肉類和乳製品感興趣》的文章，全球64%的消費者有興趣購買使用混合蛋白質來源的混合肉類和乳製品。

同時，菌絲體和真菌蛋白平台的蓬勃發展正在打造一個可擴展的第三大生產基地，它不同於植物分離蛋白和培養肉。生質能發酵技術利用絲狀真菌的纖維結構，自然模擬完整的肌肉組織，無需高壓擠壓和大規模的後處理工序。在消費者對加工程度較低的全食品的需求推動下，這項技術正迅速從試點階段邁向大規模生產。根據AgFunderNews於2025年1月發表的報導報道，真菌蛋白生產商Meati Foods在2024年成功地將其零售分銷網路同比成長了130%，並將菌絲體全切產品引入了數千家新的雜貨店。

目錄

第1章概述

第2章：調查方法

第3章執行摘要

第4章：客戶心聲

第5章：全球替代蛋白市場展望

  • 市場規模及預測
    • 按金額
  • 市佔率及預測
    • 依產品類型（植物蛋白、微生物蛋白、昆蟲蛋白）
    • 按應用領域（食品和飲料、嬰兒奶粉、臨床營養、動物飼料、其他）
    • 按地區
    • 按公司（2025 年）
  • 市場地圖

第6章：北美替代蛋白市場展望

  • 市場規模及預測
  • 市佔率及預測
  • 北美洲：國別分析
    • 美國
    • 加拿大
    • 墨西哥

第7章：歐洲替代蛋白市場展望

  • 市場規模及預測
  • 市佔率及預測
  • 歐洲：國別分析
    • 德國
    • 法國
    • 英國
    • 義大利
    • 西班牙

第8章：亞太地區替代蛋白市場展望

  • 市場規模及預測
  • 市佔率及預測
  • 亞太地區：國別分析
    • 中國
    • 印度
    • 日本
    • 韓國
    • 澳洲

第9章：中東與非洲替代蛋白市場展望

  • 市場規模及預測
  • 市佔率及預測
  • 中東與非洲：國別分析
    • 沙烏地阿拉伯
    • 阿拉伯聯合大公國
    • 南非

第10章：南美洲替代蛋白市場展望

  • 市場規模及預測
  • 市佔率及預測
  • 南美洲：國別分析
    • 巴西
    • 哥倫比亞
    • 阿根廷

第11章 市場動態

  • 促進因素
  • 任務

第12章 市場趨勢與發展

  • 併購
  • 產品發布
  • 近期趨勢

第13章：全球替代蛋白市場：SWOT分析

第14章：波特五力分析

  • 產業競爭
  • 新進入者的潛力
  • 供應商的議價能力
  • 顧客權力
  • 替代品的威脅

第15章 競爭格局

  • Archer Daniels Midland Company
  • Cargill Inc.
  • Lightlife Foods, Inc.
  • Impossible Foods Inc.
  • International Flavors & Fragrances, Inc.
  • Ingredion Inc.
  • Kerry Group
  • Glanbia plc
  • Bunge Limited
  • Axiom Foods Inc.

第16章 策略建議

第17章：關於研究公司及免責聲明

簡介目錄
Product Code: 26760

The Global Alternative Protein Market is projected to expand from USD 16.98 Billion in 2025 to USD 27.04 Billion by 2031, reflecting a compound annual growth rate of 8.06%. Defined as food products derived from plant-based ingredients, fermentation processes, or animal cell cultivation, these alternatives aim to replicate the sensory and nutritional characteristics of conventional meat. Growth is primarily driven by the urgent need to mitigate climate change and the global imperative for efficient resource usage to guarantee long-term food security, alongside increasing consumer recognition of the health advantages offered by diverse protein sources. Highlighting this momentum, the Good Food Institute reported that global sales of plant-based meat and dairy alternatives reached $28.6 billion in 2024.

Market Overview
Forecast Period2027-2031
Market Size 2025USD 16.98 Billion
Market Size 2031USD 27.04 Billion
CAGR 2026-20318.06%
Fastest Growing SegmentAnimal Feed
Largest MarketNorth America

However, the sector encounters significant hurdles arising from a constrained investment climate that limits the capital needed to scale manufacturing operations. This scarcity of financial backing impedes companies from developing the necessary infrastructure to attain technological economies of scale, thereby delaying the achievement of price parity with traditional animal products. According to the Good Food Institute, total funding for the alternative protein sector amounted to just $1.1 billion in 2024. This contraction in investment capital creates a formidable barrier to the rapid industrial expansion essential for securing mass market adoption.

Market Driver

Technological breakthroughs in extrusion and precision fermentation are crucial for surmounting the texture and cost obstacles that currently impede the widespread adoption of alternative proteins. Specifically, innovations in high-moisture extrusion facilitate the production of whole-cut meat analogues that mimic the fibrous nature of animal muscle, while precision fermentation enables the scalable creation of functional ingredients such as heme and casein. As these technologies graduate from lab-scale prototypes to industrial manufacturing, they become vital for reaching price parity with conventional meat. Per the Good Food Institute's '2024 State of the Industry: Fermentation' report, at least 17 fermentation facilities were opened or announced in 2024, indicating strong growth in global biomanufacturing capacity despite economic challenges, which directly aids in stabilizing supply chains and lowering costs.

Simultaneously, supportive government policies and regulatory frameworks are creating a stable environment for market legitimacy and sustained research and development. Governments increasingly recognize alternative proteins as strategic assets for improving national food security and achieving climate goals, resulting in significant public investment in open-access research and private incentives. The Good Food Institute's '2024 State of Global Policy' report notes that governments globally committed approximately $510 million in new funding to the sector in 2024. This influx of public capital helps de-risk early-stage innovation and supplements private funding, speeding up commercialization. The success of these drivers is reflected in consumer behavior; according to the Good Food Institute, 59% of U.S. households purchased plant-based foods in the year prior to 2025, proving that better availability and institutional backing are effectively boosting market penetration.

Market Challenge

The restricted investment environment severely impedes the Global Alternative Protein Market by limiting the capital required to scale manufacturing operations. Without adequate access to late-stage growth funds, manufacturers are unable to finance the substantial expenditures necessary for constructing large-scale production facilities. This inability to expand infrastructure prevents companies from realizing the technical economies of scale essential for reducing unit costs. As a consequence, alternative protein products continue to command a price premium over conventional meat, which stalls mass consumer adoption and confines market penetration to niche demographics.

The severity of this financial contraction is underscored by recent data illustrating a sharp decline in funding. According to the Good Food Institute, investment in plant-based protein companies dropped to $309 million in 2024, marking a significant 64% decrease from the previous year. This drastic reduction in available capital compels many firms to suspend or cancel intended facility expansions. Consequently, the industry faces difficulties in transitioning from pilot-scale operations to the industrial-grade output needed to achieve price parity and compete effectively against the traditional animal agriculture sector.

Market Trends

The rise of hybrid products that merge plant-based ingredients with fermentation-derived or cultivated components is becoming a practical strategy to address sensory limitations for flexitarian consumers. By combining various protein sources, manufacturers can offer enhanced taste and texture profiles that are difficult to achieve with pure plant-based formulations, while also optimizing cost structures and nutritional density relative to fully cultivated alternatives. This integrated approach is gaining traction as a familiar option for hesitant buyers; a July 2025 article by Green Queen titled 'Global Survey: 75% of Consumers Still Interested in Plant-Based Meat & Dairy' reported that 64% of global consumers are interested in purchasing blended meat and dairy products featuring mixed protein sources.

In parallel, the growth of mycelium and fungi-based protein platforms is creating a scalable third production pillar, separate from plant isolates and cultivated meat. Biomass fermentation leverages filamentous fungi to naturally mimic the fibrous structure of whole-cut muscle tissue, eliminating the need for heavy extrusion or extensive downstream processing. Driven by consumer demand for less processed, whole-food options, this technology is moving quickly from pilot demonstrations to mass availability. As reported by AgFunderNews in January 2025, in the article 'Meati expands distribution, anticipates positive gross margins by the year end,' fungi-based manufacturer Meati Foods expanded its retail distribution by 130% year-over-year in 2024, successfully introducing its mycelium-based whole-cut products to thousands of new grocery outlets.

Key Market Players

  • Archer Daniels Midland Company
  • Cargill Inc.
  • Lightlife Foods, Inc.
  • Impossible Foods Inc.
  • International Flavors & Fragrances, Inc.
  • Ingredion Inc.
  • Kerry Group
  • Glanbia plc
  • Bunge Limited
  • Axiom Foods Inc.

Report Scope

In this report, the Global Alternative Protein Market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:

Alternative Protein Market, By Product Type

  • Plant Proteins
  • Microbe-based Protein
  • Insect Protein

Alternative Protein Market, By Application

  • Food & Beverages
  • Infant Formulations
  • Clinical Nutrition
  • Animal Feed
  • Others

Alternative Protein Market, By Region

  • North America
    • United States
    • Canada
    • Mexico
  • Europe
    • France
    • United Kingdom
    • Italy
    • Germany
    • Spain
  • Asia Pacific
    • China
    • India
    • Japan
    • Australia
    • South Korea
  • South America
    • Brazil
    • Argentina
    • Colombia
  • Middle East & Africa
    • South Africa
    • Saudi Arabia
    • UAE

Competitive Landscape

Company Profiles: Detailed analysis of the major companies present in the Global Alternative Protein Market.

Available Customizations:

Global Alternative Protein Market report with the given market data, TechSci Research offers customizations according to a company's specific needs. The following customization options are available for the report:

Company Information

  • Detailed analysis and profiling of additional market players (up to five).

Table of Contents

1. Product Overview

  • 1.1. Market Definition
  • 1.2. Scope of the Market
    • 1.2.1. Markets Covered
    • 1.2.2. Years Considered for Study
    • 1.2.3. Key Market Segmentations

2. Research Methodology

  • 2.1. Objective of the Study
  • 2.2. Baseline Methodology
  • 2.3. Key Industry Partners
  • 2.4. Major Association and Secondary Sources
  • 2.5. Forecasting Methodology
  • 2.6. Data Triangulation & Validation
  • 2.7. Assumptions and Limitations

3. Executive Summary

  • 3.1. Overview of the Market
  • 3.2. Overview of Key Market Segmentations
  • 3.3. Overview of Key Market Players
  • 3.4. Overview of Key Regions/Countries
  • 3.5. Overview of Market Drivers, Challenges, Trends

4. Voice of Customer

5. Global Alternative Protein Market Outlook

  • 5.1. Market Size & Forecast
    • 5.1.1. By Value
  • 5.2. Market Share & Forecast
    • 5.2.1. By Product Type (Plant Proteins, Microbe-based Protein, Insect Protein)
    • 5.2.2. By Application (Food & Beverages, Infant Formulations, Clinical Nutrition, Animal Feed, Others)
    • 5.2.3. By Region
    • 5.2.4. By Company (2025)
  • 5.3. Market Map

6. North America Alternative Protein Market Outlook

  • 6.1. Market Size & Forecast
    • 6.1.1. By Value
  • 6.2. Market Share & Forecast
    • 6.2.1. By Product Type
    • 6.2.2. By Application
    • 6.2.3. By Country
  • 6.3. North America: Country Analysis
    • 6.3.1. United States Alternative Protein Market Outlook
      • 6.3.1.1. Market Size & Forecast
        • 6.3.1.1.1. By Value
      • 6.3.1.2. Market Share & Forecast
        • 6.3.1.2.1. By Product Type
        • 6.3.1.2.2. By Application
    • 6.3.2. Canada Alternative Protein Market Outlook
      • 6.3.2.1. Market Size & Forecast
        • 6.3.2.1.1. By Value
      • 6.3.2.2. Market Share & Forecast
        • 6.3.2.2.1. By Product Type
        • 6.3.2.2.2. By Application
    • 6.3.3. Mexico Alternative Protein Market Outlook
      • 6.3.3.1. Market Size & Forecast
        • 6.3.3.1.1. By Value
      • 6.3.3.2. Market Share & Forecast
        • 6.3.3.2.1. By Product Type
        • 6.3.3.2.2. By Application

7. Europe Alternative Protein Market Outlook

  • 7.1. Market Size & Forecast
    • 7.1.1. By Value
  • 7.2. Market Share & Forecast
    • 7.2.1. By Product Type
    • 7.2.2. By Application
    • 7.2.3. By Country
  • 7.3. Europe: Country Analysis
    • 7.3.1. Germany Alternative Protein Market Outlook
      • 7.3.1.1. Market Size & Forecast
        • 7.3.1.1.1. By Value
      • 7.3.1.2. Market Share & Forecast
        • 7.3.1.2.1. By Product Type
        • 7.3.1.2.2. By Application
    • 7.3.2. France Alternative Protein Market Outlook
      • 7.3.2.1. Market Size & Forecast
        • 7.3.2.1.1. By Value
      • 7.3.2.2. Market Share & Forecast
        • 7.3.2.2.1. By Product Type
        • 7.3.2.2.2. By Application
    • 7.3.3. United Kingdom Alternative Protein Market Outlook
      • 7.3.3.1. Market Size & Forecast
        • 7.3.3.1.1. By Value
      • 7.3.3.2. Market Share & Forecast
        • 7.3.3.2.1. By Product Type
        • 7.3.3.2.2. By Application
    • 7.3.4. Italy Alternative Protein Market Outlook
      • 7.3.4.1. Market Size & Forecast
        • 7.3.4.1.1. By Value
      • 7.3.4.2. Market Share & Forecast
        • 7.3.4.2.1. By Product Type
        • 7.3.4.2.2. By Application
    • 7.3.5. Spain Alternative Protein Market Outlook
      • 7.3.5.1. Market Size & Forecast
        • 7.3.5.1.1. By Value
      • 7.3.5.2. Market Share & Forecast
        • 7.3.5.2.1. By Product Type
        • 7.3.5.2.2. By Application

8. Asia Pacific Alternative Protein Market Outlook

  • 8.1. Market Size & Forecast
    • 8.1.1. By Value
  • 8.2. Market Share & Forecast
    • 8.2.1. By Product Type
    • 8.2.2. By Application
    • 8.2.3. By Country
  • 8.3. Asia Pacific: Country Analysis
    • 8.3.1. China Alternative Protein Market Outlook
      • 8.3.1.1. Market Size & Forecast
        • 8.3.1.1.1. By Value
      • 8.3.1.2. Market Share & Forecast
        • 8.3.1.2.1. By Product Type
        • 8.3.1.2.2. By Application
    • 8.3.2. India Alternative Protein Market Outlook
      • 8.3.2.1. Market Size & Forecast
        • 8.3.2.1.1. By Value
      • 8.3.2.2. Market Share & Forecast
        • 8.3.2.2.1. By Product Type
        • 8.3.2.2.2. By Application
    • 8.3.3. Japan Alternative Protein Market Outlook
      • 8.3.3.1. Market Size & Forecast
        • 8.3.3.1.1. By Value
      • 8.3.3.2. Market Share & Forecast
        • 8.3.3.2.1. By Product Type
        • 8.3.3.2.2. By Application
    • 8.3.4. South Korea Alternative Protein Market Outlook
      • 8.3.4.1. Market Size & Forecast
        • 8.3.4.1.1. By Value
      • 8.3.4.2. Market Share & Forecast
        • 8.3.4.2.1. By Product Type
        • 8.3.4.2.2. By Application
    • 8.3.5. Australia Alternative Protein Market Outlook
      • 8.3.5.1. Market Size & Forecast
        • 8.3.5.1.1. By Value
      • 8.3.5.2. Market Share & Forecast
        • 8.3.5.2.1. By Product Type
        • 8.3.5.2.2. By Application

9. Middle East & Africa Alternative Protein Market Outlook

  • 9.1. Market Size & Forecast
    • 9.1.1. By Value
  • 9.2. Market Share & Forecast
    • 9.2.1. By Product Type
    • 9.2.2. By Application
    • 9.2.3. By Country
  • 9.3. Middle East & Africa: Country Analysis
    • 9.3.1. Saudi Arabia Alternative Protein Market Outlook
      • 9.3.1.1. Market Size & Forecast
        • 9.3.1.1.1. By Value
      • 9.3.1.2. Market Share & Forecast
        • 9.3.1.2.1. By Product Type
        • 9.3.1.2.2. By Application
    • 9.3.2. UAE Alternative Protein Market Outlook
      • 9.3.2.1. Market Size & Forecast
        • 9.3.2.1.1. By Value
      • 9.3.2.2. Market Share & Forecast
        • 9.3.2.2.1. By Product Type
        • 9.3.2.2.2. By Application
    • 9.3.3. South Africa Alternative Protein Market Outlook
      • 9.3.3.1. Market Size & Forecast
        • 9.3.3.1.1. By Value
      • 9.3.3.2. Market Share & Forecast
        • 9.3.3.2.1. By Product Type
        • 9.3.3.2.2. By Application

10. South America Alternative Protein Market Outlook

  • 10.1. Market Size & Forecast
    • 10.1.1. By Value
  • 10.2. Market Share & Forecast
    • 10.2.1. By Product Type
    • 10.2.2. By Application
    • 10.2.3. By Country
  • 10.3. South America: Country Analysis
    • 10.3.1. Brazil Alternative Protein Market Outlook
      • 10.3.1.1. Market Size & Forecast
        • 10.3.1.1.1. By Value
      • 10.3.1.2. Market Share & Forecast
        • 10.3.1.2.1. By Product Type
        • 10.3.1.2.2. By Application
    • 10.3.2. Colombia Alternative Protein Market Outlook
      • 10.3.2.1. Market Size & Forecast
        • 10.3.2.1.1. By Value
      • 10.3.2.2. Market Share & Forecast
        • 10.3.2.2.1. By Product Type
        • 10.3.2.2.2. By Application
    • 10.3.3. Argentina Alternative Protein Market Outlook
      • 10.3.3.1. Market Size & Forecast
        • 10.3.3.1.1. By Value
      • 10.3.3.2. Market Share & Forecast
        • 10.3.3.2.1. By Product Type
        • 10.3.3.2.2. By Application

11. Market Dynamics

  • 11.1. Drivers
  • 11.2. Challenges

12. Market Trends & Developments

  • 12.1. Merger & Acquisition (If Any)
  • 12.2. Product Launches (If Any)
  • 12.3. Recent Developments

13. Global Alternative Protein Market: SWOT Analysis

14. Porter's Five Forces Analysis

  • 14.1. Competition in the Industry
  • 14.2. Potential of New Entrants
  • 14.3. Power of Suppliers
  • 14.4. Power of Customers
  • 14.5. Threat of Substitute Products

15. Competitive Landscape

  • 15.1. Archer Daniels Midland Company
    • 15.1.1. Business Overview
    • 15.1.2. Products & Services
    • 15.1.3. Recent Developments
    • 15.1.4. Key Personnel
    • 15.1.5. SWOT Analysis
  • 15.2. Cargill Inc.
  • 15.3. Lightlife Foods, Inc.
  • 15.4. Impossible Foods Inc.
  • 15.5. International Flavors & Fragrances, Inc.
  • 15.6. Ingredion Inc.
  • 15.7. Kerry Group
  • 15.8. Glanbia plc
  • 15.9. Bunge Limited
  • 15.10. Axiom Foods Inc.

16. Strategic Recommendations

17. About Us & Disclaimer